Syntex
Executive Summary
Purchased 17% interest in privately held American Bionuclear for undisclosed terms. Syntex will also market certain American Bionuclear products. American Bionuclear has a number of diagnostic DNA probes under development. Minority purchase is Syntex' third since January. Firm has also invested in Oregon-based Epitope, and Chicago-based Xytronyx.